Researchers characterize neurologic response associated with placebo effect

Parkinson's disease is the second most common neurological disorder, affecting almost 10 million people worldwide. While there is no cure for this disease, many patients are able to successfully manage their symptoms. Surgical interventions appear to provide relief for some patients.

Unfortunately, these procedures have been difficult to fully evaluate because many patients have a strong placebo response to sham surgery in clinical trials. A new study in the Journal of Clinical Investigation identifies a neurological network that may predict patients that are likely to have a favorable response to sham surgery. David Eidelberg and colleagues at the Feinstein Institute for Medical Research evaluated Parkinson's disease patients enrolled in a double blind gene therapy trial. Brain networks were evaluated prior to the sham surgery and after recovery. Patients that responded favorably to sham surgery expressed a distinct neurological profile. After it was revealed to these patients that they were part of the , their perceived improvements declined and their neurological network more closely resembled the pre-surgery profile.

In their accompanying commentary, Mariya Cherkasova and A. Jon Stoessl at University of British Columbia note that the ability to identify sham responders may limit placebo effects in and help better identify efficacious treatments.

More information: J Clin Invest. DOI: 10.1172/JCI75073.

add to favorites email to friend print save as pdf

Related Stories

Targeted exercise relieves sciatica pain

Apr 09, 2012

(HealthDay) -- Active conservative symptom-guided therapy for severe sciatica can safely reduce pain and improve neurological function at a rate that matches or surpasses outcomes from common higher-cost surgical ...

Placebo effects of different therapies not identical

Jul 31, 2013

Not all placebos are equal, and patients who respond to one placebo don't always respond to others, according to research published July 31 in the open access journal PLOS ONE by Jian Kong from Massachusetts General Hospit ...

Recommended for you

Sierra Leone, Liberia brace for new Ebola cases

11 hours ago

Two of the West African nations hardest hit by Ebola were bracing for new caseloads on Monday after trying to outflank the outbreak with a nationwide checkup and a large new clinic.

Reversing the effects of pulmonary fibrosis

12 hours ago

Yale University researchers are studying a potential new treatment that reverses the effects of pulmonary fibrosis, a respiratory disease in which scars develop in the lungs and severely hamper breathing.

User comments